Reproducibility of EASL criteria and modified RECIST in patients treated with sorafenib

ConclusionsThe reproducibility of the EASLc and mRECIST in assessing treatment outcomes was high in patients with advanced HCC treated with sorafenib.This article is protected by copyright. All rights reserved.

Source: Liver International - March 1, 2018 Category: Gastroenterology Authors: Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang ‐Hyub Han, Song‐Ee Baek, Hye Soo Kim, Seung Up Kim, Mi Suk Park Tags: Original Article Source Type: research